Anavex Life Sciences Corp.
AVXL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001314052
No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Anavex Life Sciences Corp. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 186
- +3 vs. Q3 2025
- Shares held
- 37.9M
- +5.30M (+16.3%) vs. Q3 2025
- Total value
- $136.1M
- −$151.3M (−52.7%) vs. Q3 2025
- New holders
- 29
- 62 more added
- Sold out
- 26
- 54 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVXL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $95.8M |
| Q1 2026 | 190 | $122.7M |
| Q4 2025 | 186 | $136.1M |
| Q3 2025 | 186 | $289.3M |
| Q2 2025 | 178 | $301.9M |
| Q1 2025 | 181 | $269.2M |
| Q4 2024 | 169 | $316.5M |
| Q3 2024 | 145 | $153.2M |
| Q2 2024 | 141 | $113.3M |
| Q1 2024 | 147 | $161.3M |
| Q4 2023 | 153 | $240.8M |
| Q3 2023 | 143 | $164.1M |
| Q2 2023 | 144 | $205.6M |
| Q1 2023 | 141 | $232.3M |
| Q4 2022 | 139 | $248.7M |
| Q3 2022 | 148 | $251.4M |
| Q2 2022 | 150 | $249.4M |
| Q1 2022 | 139 | $308.2M |
| Q4 2021 | 149 | $383.2M |
| Q3 2021 | 136 | $370.1M |
| Q2 2021 | 127 | $492.2M |
| Q1 2021 | 108 | $271.9M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Anavex Life Sciences Corp.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Strategic Family Wealth Counselors, L.L.C. | 0 | $0 | 0.00% | −7,545−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −4,049−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −1,484−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Graney & King, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Atlantic Union Bankshares Corp | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Sheets Smith Investment Management | – | – | – | – | Not filed |
| AllSquare Wealth Management LLC | – | – | – | – | Not filed |
| Watts Gwilliam & Co., LLC | – | – | – | – | Not filed |